COVID-19 mRNA Vaccination Generates Greater Immunoglobulin G Levels in Women Compared to Men.

COVID-19 mRNA Vaccination Generates Greater Immunoglobulin G Levels in Women Compared to Men.
复制标题

DOI:
10.1093/infdis/jiab314
复制
发表时间:
2021-09-01
期刊:
The Journal of infectious diseases
影响因子:
--
通讯作者:
McNally EM
McNally EM
中科院分区:
其他
文献类型:
--
作者:
Demonbreun AR;Sancilio A;Velez ME;Ryan DT;Pesce L;Saber R;Vaught LA;Reiser NL;Hsieh RR;D'Aquila RT;Mustanski B;McDade TW;McNally EM

文献摘要

参考文献

被引文献

相似文献

我们调查了女性和男性对 2019 年冠状病毒病 (COVID-19) mRNA 疫苗接种的抗体反应是否相似。在之前没有感染过 COVID-19 的社区队列中,与男性相比,女性第一剂疫苗产生了更高的免疫球蛋白 G (IgG) 水平和刺突 ACE2 受体结合抑制百分比(病毒中和的替代指标)(7.0 µg/mL,51.6% vs 3.3 µg/mL,36.4%)。两次给药后,女性 IgG 水平 (30.4 µg/mL) 仍显着高于男性 (20.6 µg/mL),而抑制百分比相似(98.4% vs 97.7%)。对 mRNA 疫苗接种的性别特异性抗体反应为未来了解疫苗保护和副作用的努力提供了信息。
We investigated whether the antibody response to coronavirus disease 2019 (COVID-19) mRNA vaccination is similar in women and men. In a community cohort without prior COVID-19, first vaccine dose produced higher immunoglobulin G (IgG) levels and percent inhibition of spike-ACE2 receptor binding, a surrogate measure of virus neutralization, in women compared to men (7.0 µg/mL, 51.6% vs 3.3 µg/mL, 36.4%). After 2 doses, IgG levels remained significantly higher for women (30.4 µg/mL) compared to men (20.6 µg/mL), while percent inhibition was similar (98.4% vs 97.7%). Sex-specific antibody response to mRNA vaccination informs future efforts to understand vaccine protection and side effects.
BNT162B2 mRNA COVID-19疫苗的安全性和功效。
DOI: 10.1056/nejmoa2034577
发表时间: 2020-12-31
期刊: The New England journal of medicine
影响因子: --
作者:
Polack FP;Thomas SJ;Kitchin N;Absalon J;Gurtman A;Lockhart S;Perez JL;Pérez Marc G;Moreira ED;Zerbini C;Bailey R;Swanson KA;Roychoudhury S;Koury K;Li P;Kalina WV;Cooper D;Frenck RW Jr;Hammitt LL;Türeci Ö;Nell H;Schaefer A;Ünal S;Tresnan DB;Mather S;Dormitzer PR;Şahin U;Jansen KU;Gruber WC;C4591001 Clinical Trial Group
通讯作者: C4591001 Clinical Trial Group
DOI: 10.1093/infdis/jiab127
发表时间: 2021-08-12
影响因子: 6.4
作者:
Grzelak, Ludivine;Velay, Aurelie;Fafi-Kremer, Samira
通讯作者: Fafi-Kremer, Samira
DOI: 10.1038/s41591-020-0913-5
发表时间: 2020-07
期刊: Nature medicine
影响因子: 82.9
作者:
Amanat F;Stadlbauer D;Strohmeier S;Nguyen THO;Chromikova V;McMahon M;Jiang K;Arunkumar GA;Jurczyszak D;Polanco J;Bermudez-Gonzalez M;Kleiner G;Aydillo T;Miorin L;Fierer DS;Lugo LA;Kojic EM;Stoever J;Liu STH;Cunningham-Rundles C;Felgner PL;Moran T;García-Sastre A;Caplivski D;Cheng AC;Kedzierska K;Vapalahti O;Hepojoki JM;Simon V;Krammer F
通讯作者: Krammer F
DOI: 10.1371/journal.pone.0237833
发表时间: 2020-08-14
期刊: PLOS ONE
影响因子: 3.7
作者:
McDade, Thomas W.;McNally, Elizabeth M.;Demonbreun, Alexis R.
通讯作者: Demonbreun, Alexis R.
DOI: 10.15585/mmwr.mm7008e3
发表时间: 2021-02-26
期刊: MMWR. Morbidity and mortality weekly report
影响因子: --
作者:
Gee J;Marquez P;Su J;Calvert GM;Liu R;Myers T;Nair N;Martin S;Clark T;Markowitz L;Lindsey N;Zhang B;Licata C;Jazwa A;Sotir M;Shimabukuro T
通讯作者: Shimabukuro T